Table 1. The 100 ‘citation classics’ regarding the field of lung cancer surgery and the number of calculated annual citations.
| Rank | Article | Citations | Citations per year | PMID |
|---|---|---|---|---|
| 1 | Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non-Small-Cell Lung Cancer | 1,720 | 122.86 | 14736927 |
| 2 | Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer | 1,623 | 70.57 | 7677489 |
| 3 | Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer | 1,372 | 105.54 | 15972865 |
| 4 | A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer | 1,095 | 45.63 | 8043059 |
| 5 | Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial | 1,014 | 84.50 | 16945766 |
| 6 | A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage iiia non-small-cell lung cancer | 962 | 40.08 | 8156698 |
| 7 | Incidence of local recurrence and second primary tumors in resected stage I lung cancer | 763 | 33.17 | 7815787 |
| 8 | Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group Phase II Study 8805 | 746 | 32.43 | 7636530 |
| 9 | Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial | 739 | 82.11 | 19632716 |
| 10 | Prognosis and survival in resected lung carcinoma based on the new international staging system | 633 | 21.10 | 2842549 |
| 11 | Lymph node mapping and curability at various levels of metastasis in resected lung cancer | 598 | 14.95 | 713589 |
| 12 | Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer | 523 | 32.69 | 11773176 |
| 13 | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials | 521 | 173.67 | 25981812 |
| 14 | Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer | 515 | 18.39 | 1979160 |
| 15 | Modern thirty-day operative mortality for surgical resections in lung cancer | 501 | 14.31 | 6632940 |
| 16 | The influence of hospital volume on survival after resection for lung cancer | 470 | 27.65 | 11463014 |
| 17 | Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer | 445 | 29.67 | 14519751 |
| 18 | Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer | 439 | 39.91 | 17762333 |
| 19 | A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer | 419 | 23.28 | 11355584 |
| 20 | Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 trial | 418 | 34.83 | 16488712 |
| 21 | Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer | 406 | 45.11 | 19289625 |
| 22 | Radical sublobar resection for small-sized non-small cell lung cancer: A multicenter study | 402 | 33.50 | 17000286 |
| 23 | Guidelines on the selection of patients with lung cancer for surgery | 394 | 23.18 | 11209097 |
| 24 | Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer | 392 | 19.60 | 9792048 |
| 25 | Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications | 384 | 21.33 | 10944131 |
| 26 | ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) | 382 | 42.44 | 19567600 |
| 27 | Effects of Postoperative Mediastinal Radiation on Completely Resected Stage II and Stage III Epidermoid Cancer of the Lung | 375 | 11.72 | 2877397 |
| 28 | The role of surgery in N2 lung cancer | 357 | 11.52 | 3629423 |
| 29 | Surgery for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review of the Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Approaches to Lobectomy | 345 | 34.50 | 19022040 |
| 30 | Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition) | 338 | 30.73 | 17873167 |
| 31 | Stereotactic body radiotherapy (SBRT) for operable Stage i non-small-cell lung cancer: Can SBRT be comparable to surgery? | 328 | 46.86 | 20638194 |
| 32 | Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients | 320 | 35.56 | 19255323 |
| 33 | The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups | 308 | 51.33 | 22710039 |
| 34 | Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial | 307 | 15.35 | 9469351 |
| 35 | Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer | 302 | 33.56 | 19185164 |
| 36 | Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer | 299 | 14.24 | 9104978 |
| 37 | The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer | 296 | 18.50 | 11812957 |
| 38 | Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection | 292 | 20.86 | 15310769 |
| 39 | Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases | 289 | 8.26 | 6615059 |
| 40 | Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer | 283 | 35.38 | 20065181 |
| 41 | A Japanese lung cancer registry study: Prognosis of 13,010 resected lung cancers | 280 | 28.00 | 18166840 |
| 42 | Prognostic Significance of p53 Mutations and 3p Deletions in Primary Resected Non-Small Cell Lung Cancer | 280 | 11.20 | 8380124 |
| 43 | Adjuvant chemotherapy after complete resection in non-small-cell lung cancer | 275 | 12.50 | 23931022 |
| 44 | Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer | 266 | 14.78 | 10594199 |
| 45 | Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer | 264 | 33.00 | 20823422 |
| 46 | Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer | 263 | 12.52 | 20823422 |
| 47 | Risk Factors for Acute Lung Injury after Thoracic Surgery for Lung Cancer | 261 | 17.40 | 14633519 |
| 48 | Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non- small-cell lung cancer: Amphiregulin and microvessel count are independent prognostic indicators of survival | 256 | 12.80 | 9516978 |
| 49 | Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: Long-term results of Southwest Oncology Group trial 9416 (Intergroup trial 0160) | 254 | 23.09 | 17235046 |
| 50 | Sites of recurrence in resected stage I non-small-cell lung cancer: A guide for future studies | 251 | 7.38 | 6512581 |
| 51 | Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer | 246 | 27.33 | 19577048 |
| 52 | Intentional limited resection for selected patients with T1 N0 M0 non- small-cell lung cancer: A single-institution study |
244 | 11.62 | 9305186 |
| 53 | The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A lung cancer study group trial | 243 | 9.00 | 2072706 |
| 54 | Patient and hospital characteristics related to in-hospital mortality after lung cancer resection | 240 | 9.23 | 1582293 |
| 55 | Morbidity and mortality after neoadjuvant therapy for lung cancer: The risks of right pneumonectomy | 238 | 14.00 | 11603428 |
| 56 | ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer | 238 | 18.31 | 15764785 |
| 57 | Effect of tumor size on prognosis in patients with non-small cell lung cancer: The role of segmentectomy as a type of lesser resection | 236 | 18.15 | 15632829 |
| 58 | Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer | 236 | 59.00 | 25009014 |
| 59 | miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer | 234 | 26.00 | 19736307 |
| 60 | Segmental resection spares pulmonary function in patients with stage I lung cancer | 233 | 16.64 | 15223434 |
| 61 | 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer | 232 | 14.50 | 11801701 |
| 62 | The Importance of Surgery to Non-Small Cell Carcinoma of Lung with Mediastinal Lymph Node Metastasis | 231 | 7.70 | 2848463 |
| 63 | The physiologic evaluation of patients with lung cancer being considered for resectional surgery | 229 | 15.27 | 12527570 |
| 64 | Induction chemotherapy before surgery for early-stage lung cancer: A novel approach | 229 | 12.72 | 10694600 |
| 65 | Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non-Small Cell Lung Cancer: A 13-Year Analysis | 226 | 18.83 | 16863738 |
| 66 | Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: Updated survival analysis of JBR-10 | 226 | 28.25 | 19933915 |
| 67 | Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer | 226 | 15.07 | 12698157 |
| 68 | Long-term results of the international adjuvant lung cancer trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer | 223 | 27.88 | 19933916 |
| 69 | A Phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L) | 222 | 24.67 | 19933688 |
| 70 | Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database | 222 | 17.08 | 16002941 |
| 71 | Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines | 221 | 44.20 | 23649437 |
| 72 | Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy? | 220 | 10.00 | 8642812 |
| 73 | Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of southwest oncology group trial 9416 (Intergroup Trial 0160) | 217 | 12.76 | 11241082 |
| 74 | A controlled study of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma | 214 | 11.26 | 10994397 |
| 75 | Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? | 212 | 12.47 | 11269480 |
| 76 | A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy | 212 | 8.83 | 7988254 |
| 77 | Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: Report of a cancer and leukemia group B phase II study | 212 | 8.15 | 1321893 |
| 78 | Prognostic factors in patients with resected stage I non‐small cell lung cancer. A report from the Lung Cancer Study Group | 211 | 6.21 | 6478416 |
| 79 | What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery | 211 | 13.19 | 12114334 |
| 80 | Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after Resection for Lung Cancer | 206 | 18.73 | 17383320 |
| 81 | Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer | 205 | 9.32 | 8562333 |
| 82 | Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry study | 203 | 15.62 | 16061304 |
| 83 | Complete resection in lung cancer surgery: Proposed definition | 202 | 15.54 | 15949587 |
| 84 | Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA | 201 | 11.17 | 10669677 |
| 85 | Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection | 200 | 25.00 | 20028859 |
| 86 | Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer | 199 | 14.21 | 14679115 |
| 87 | Preoperative risk evaluation for lung cancer resection: Predicted postoperative product as a predictor of surgical mortality | 198 | 8.25 | 7921468 |
| 88 | Adjuvant MAGE-A3 immunotherapy in resected non–small-cell lung cancer: Phase II randomized study results | 197 | 39.40 | 23715567 |
| 89 | Video-assisted thoracic surgery versus open lobectomy for lung cancer: A secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial | 196 | 24.50 | 20172539 |
| 90 | Impact of Postoperative Radiation Therapy on Survival in Patients With Complete Resection and Stage I, II, or IIIA Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial | 196 | 19.60 | 18439766 |
| 91 | Video-Assisted Thoracoscopic Surgery is More Favorable Than Thoracotomy for Resection of Clinical Stage I Non-Small Cell Lung Cancer | 195 | 17.73 | 17532379 |
| 92 | Resection rates and postoperative mortality in 7,899 patients with lung cancer | 194 | 8.82 | 8834326 |
| 93 | Complications of surgery in the treatment of carcinoma of the lung | 191 | 5.31 | 7083931 |
| 94 | Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer | 185 | 6.17 | 2849147 |
| 95 | Postoperative radiation therapy in lung cancer: A controlled trial after resection of curative design | 183 | 4.82 | 6998936 |
| 96 | BRCA1: A novel prognostic factor in resected non-small-cell lung cancer | 182 | 16.55 | 17987116 |
| 97 | Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy: A Southwest Oncology Group trial | 182 | 7.28 | 8380477 |
| 98 | Global histone modifications predict prognosis of resected non-small-cell lung cancer | 181 | 16.45 | 17906200 |
| 99 | Cancer recurrence after resection: T1 N0 non-small cell lung cancer | 181 | 6.46 | 2154958 |
| 100 | A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: Development and international validation studies | 177 | 29.50 | 22285053 |